vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and FIRST CAPITAL INC (FCAP). Click either name above to swap in a different company.

FIRST CAPITAL INC is the larger business by last-quarter revenue ($13.5M vs $7.8M, roughly 1.7× CRYO CELL INTERNATIONAL INC). FIRST CAPITAL INC runs the higher net margin — 36.2% vs -48.7%, a 84.9% gap on every dollar of revenue. On growth, FIRST CAPITAL INC posted the faster year-over-year revenue change (19.0% vs -2.3%). FIRST CAPITAL INC produced more free cash flow last quarter ($19.9M vs $1.2M). Over the past eight quarters, FIRST CAPITAL INC's revenue compounded faster (13.4% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Capital First Ltd, formerly known as Future Capital Holdings, was an Indian non-bank financial institution which provided debt financing. In December 2018, it was merged into IDFC Bank to form IDFC First Bank. The company was listed on the NSE and BSE prior to the merger.

CCEL vs FCAP — Head-to-Head

Bigger by revenue
FCAP
FCAP
1.7× larger
FCAP
$13.5M
$7.8M
CCEL
Growing faster (revenue YoY)
FCAP
FCAP
+21.2% gap
FCAP
19.0%
-2.3%
CCEL
Higher net margin
FCAP
FCAP
84.9% more per $
FCAP
36.2%
-48.7%
CCEL
More free cash flow
FCAP
FCAP
$18.7M more FCF
FCAP
$19.9M
$1.2M
CCEL
Faster 2-yr revenue CAGR
FCAP
FCAP
Annualised
FCAP
13.4%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
FCAP
FCAP
Revenue
$7.8M
$13.5M
Net Profit
$-3.8M
$4.9M
Gross Margin
77.9%
Operating Margin
-50.6%
Net Margin
-48.7%
36.2%
Revenue YoY
-2.3%
19.0%
Net Profit YoY
-105.1%
49.6%
EPS (diluted)
$-0.46
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
FCAP
FCAP
Q4 25
$7.8M
$13.5M
Q3 25
$7.8M
$13.3M
Q2 25
$7.9M
$12.4M
Q1 25
$8.0M
$11.4M
Q4 24
$8.0M
$11.3M
Q3 24
$8.1M
$10.9M
Q2 24
$8.0M
$10.7M
Q1 24
$7.9M
$10.5M
Net Profit
CCEL
CCEL
FCAP
FCAP
Q4 25
$-3.8M
$4.9M
Q3 25
$749.4K
$4.5M
Q2 25
$355.8K
$3.8M
Q1 25
$282.9K
$3.2M
Q4 24
$-1.9M
$3.3M
Q3 24
$1.1M
$2.9M
Q2 24
$655.8K
$2.8M
Q1 24
$556.2K
$3.0M
Gross Margin
CCEL
CCEL
FCAP
FCAP
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
FCAP
FCAP
Q4 25
-50.6%
Q3 25
24.3%
41.8%
Q2 25
18.8%
37.2%
Q1 25
13.3%
34.2%
Q4 24
-1.5%
34.8%
Q3 24
17.2%
31.5%
Q2 24
17.3%
31.1%
Q1 24
10.5%
33.0%
Net Margin
CCEL
CCEL
FCAP
FCAP
Q4 25
-48.7%
36.2%
Q3 25
9.6%
33.8%
Q2 25
4.5%
30.4%
Q1 25
3.5%
28.3%
Q4 24
-23.2%
28.8%
Q3 24
13.0%
26.5%
Q2 24
8.2%
26.5%
Q1 24
7.1%
28.1%
EPS (diluted)
CCEL
CCEL
FCAP
FCAP
Q4 25
$-0.46
$1.45
Q3 25
$0.09
$1.34
Q2 25
$0.04
$1.13
Q1 25
$0.03
$0.97
Q4 24
$-0.23
$0.97
Q3 24
$0.13
$0.87
Q2 24
$0.08
$0.85
Q1 24
$0.07
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
FCAP
FCAP
Cash + ST InvestmentsLiquidity on hand
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$137.8M
Total Assets
$61.7M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
FCAP
FCAP
Q4 25
$3.3M
Q3 25
$3.2M
Q2 25
$4.4M
Q1 25
$3.5M
Q4 24
$3.5M
Q3 24
$2.1M
Q2 24
$1.5M
Q1 24
$979.6K
Total Debt
CCEL
CCEL
FCAP
FCAP
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
FCAP
FCAP
Q4 25
$-18.6M
$137.8M
Q3 25
$-14.8M
$132.4M
Q2 25
$-15.6M
$123.2M
Q1 25
$-14.7M
$120.1M
Q4 24
$-13.2M
$114.6M
Q3 24
$-9.6M
$116.8M
Q2 24
$-10.7M
$107.8M
Q1 24
$-10.3M
$105.7M
Total Assets
CCEL
CCEL
FCAP
FCAP
Q4 25
$61.7M
$1.3B
Q3 25
$63.2M
$1.2B
Q2 25
$64.4M
$1.2B
Q1 25
$64.4M
$1.2B
Q4 24
$64.7M
$1.2B
Q3 24
$62.9M
$1.2B
Q2 24
$62.6M
$1.2B
Q1 24
$61.7M
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
FCAP
FCAP
Operating Cash FlowLast quarter
$1.3M
$21.3M
Free Cash FlowOCF − Capex
$1.2M
$19.9M
FCF MarginFCF / Revenue
15.5%
147.7%
Capex IntensityCapex / Revenue
0.9%
10.0%
Cash ConversionOCF / Net Profit
4.36×
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$35.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
FCAP
FCAP
Q4 25
$1.3M
$21.3M
Q3 25
$2.5M
$7.9M
Q2 25
$707.0K
$3.7M
Q1 25
$954.1K
$4.4M
Q4 24
$2.2M
$22.3M
Q3 24
$2.4M
$7.6M
Q2 24
$1.8M
$3.5M
Q1 24
$-356.9K
$7.2M
Free Cash Flow
CCEL
CCEL
FCAP
FCAP
Q4 25
$1.2M
$19.9M
Q3 25
$2.5M
$7.8M
Q2 25
$644.6K
$3.5M
Q1 25
$892.0K
$4.2M
Q4 24
$2.1M
$21.6M
Q3 24
$2.3M
$7.5M
Q2 24
$21.5K
$3.3M
Q1 24
$-814.6K
$7.1M
FCF Margin
CCEL
CCEL
FCAP
FCAP
Q4 25
15.5%
147.7%
Q3 25
31.9%
58.6%
Q2 25
8.1%
27.8%
Q1 25
11.2%
36.5%
Q4 24
26.8%
190.7%
Q3 24
27.9%
68.6%
Q2 24
0.3%
31.2%
Q1 24
-10.4%
67.2%
Capex Intensity
CCEL
CCEL
FCAP
FCAP
Q4 25
0.9%
10.0%
Q3 25
0.5%
1.2%
Q2 25
0.8%
2.2%
Q1 25
0.8%
1.9%
Q4 24
0.1%
6.3%
Q3 24
2.3%
0.8%
Q2 24
21.8%
1.4%
Q1 24
5.8%
1.5%
Cash Conversion
CCEL
CCEL
FCAP
FCAP
Q4 25
4.36×
Q3 25
3.38×
1.77×
Q2 25
1.99×
0.99×
Q1 25
3.37×
1.36×
Q4 24
6.84×
Q3 24
2.32×
2.62×
Q2 24
2.70×
1.23×
Q1 24
-0.64×
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons